Contrary to expectations, knockout of CLCA1 via CRISPR technology led to enhanced proliferation and metastasis of tumor cells, indicating that high expression of CLCA1 suppresses Wnt signaling and the EMT process, thereby inhibiting tumor growth.498. This evidence concerns the gene CLCA1 and neoplasm.